Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1109 of 1,261
  1. US 7067633

    Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  2. US 7067256

    Ribozyme mediated inactivation of the androgen receptor

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  3. US 7067546

    Crystal and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  4. US 7067537

    Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  5. US RE39146

    Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof

    BRACCO INT BV [NL] · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  6. US 7067254

    Diagnosis and treatment of inflammation and hyperactive immune conditions

    The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  7. US 7064112

    Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

    CAN-FITE BIOPHARMA LTD. · Granted Jun 20, 2006 · Expires Jun 15, 2026

    granted
  8. US 7064106

    Gene and use thereof

    Takeda Chemical Industries Ltd. · Granted Jun 20, 2006 · Expires Jun 15, 2026

    granted
  9. US 7064141

    Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy

    Takeda Pharmaceutical Company Limited · Granted Jun 20, 2006 · Expires Jun 15, 2026

    granted
  10. US 7063847

    Compositions and methods for enhancing immune responses mediated by antigen-presenting cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 20, 2006 · Expires Jun 15, 2026

    granted
  11. US 7064181

    Physiologically active peptide and its use

    Takeda Pharmaceutical Company Limited · Granted Jun 20, 2006 · Expires Jun 15, 2026

    granted
  12. US 7063840

    TIE-2 ligands, methods of making and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 20, 2006 · Expires Jun 15, 2026

    granted
  13. US 2006127471

    Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy

    CERAMOPTEC IND INC [DE] · Granted Jun 15, 2006 · Expires Jun 10, 2026

    granted
  14. US 7060672

    Cyclosporin analog formulations

    Isotechnika, Inc. · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  15. US 7060466

    Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene

    The Board of Regents of the University of Oklahoma · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  16. US 7060837

    Method for the purification of lansoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  17. US 7060824

    Pyrrolotriazolopyrimidinone derivatives

    Almirall Prodesfarma S.A. · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  18. US 7061237

    Remote NMR/MRI detection of laser polarized gases

    The Regents of the University of California · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  19. US 7060442

    Modulators on Nod2 signaling

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  20. US 7060113

    Hair coloring composition and method

    HairMarker LLC · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  21. US 7060259

    Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)

    Nektar Therapeutics AL, Corporation · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  22. US 7060256

    Increased peroxide content tooth bleaching gel

    DISCUS DENTAL, LLC · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  23. US 7060276

    Plasmodium falciparum AMA-1 protein and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted
  24. US 7060689

    Methods and compositions for delivery and retention of active agents to lymph nodes

    The Board of Regents of the University of Texas System · Granted Jun 13, 2006 · Expires Jun 8, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.